PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Genetic ‘episignatures’ guide researchers in identifying causes of unsolved epileptic neurological disorders

Genetic ‘episignatures’ guide researchers in identifying causes of unsolved epileptic neurological disorders
2024-08-06
(Press-News.org)

(Memphis, Tenn. – August 6, 2024) To effectively treat a disease or disorder, doctors must first know the root cause. Such is the case for developmental and epileptic encephalopathies (DEEs), whose root causes can be hugely complex and heterogeneous. Scientists at St. Jude Children’s Research Hospital demonstrated the value of DNA methylation patterns for identifying the root cause of DEEs, showing specific gene methylation and genome-wide methylation “episignatures” can help identify the genes that cause DEE. The findings were published today in Nature Communications. 

 

DEEs affect 1 in 590 children and involve more than 825 genes. Current testing methods can clinically identify the root cause, or etiology, of approximately 50% of individuals’ DEEs, which guides clinicians and families to appropriate care and support. However, the remaining half of all patients remain unsolved.

 

“About half of the patients with DEE will get a diagnosis, and half of them won’t,” said co-corresponding author Heather Mefford, MD, PhD, St. Jude Center for Pediatric Neurological Disease Research and Department of Cell & Molecular Biology. 

 

When a child is diagnosed with DEE, linking the encephalopathy to a specific gene can allow the clinician to provide appropriate treatment or control over the symptoms of the disorder. This knowledge is also invaluable to the family. 

 

“The half who do not receive diagnosis not only won’t be able to get gene-specific recommendations in their therapy, they won’t be able to link with family organizations that can connect them with other families with children that also have mutations in that gene,” explained Mefford.

 

The value of identifying rare genetic links to DEE

 

Addressing the genetic root causes for DEEs has been a long-term goal for Mefford, who was instrumental in raising the number of diagnosable cases to 50%, up from approximately 5% just a decade ago.

 

Today, 80% of identifiable DEEs can be explained by 27 genes. To tackle the remaining unsolved cases, the numerous rare occurrences of the disorder must be identified, a challenge that co-first author and St. Jude Graduate School of Biomedical Sciences student Christy LaFlamme embraced. 

 

“One way we can get at the remaining 50% is by exploring what traditional tests don’t look at,” said LaFlamme. “Current tests don’t look at noncoding space that regulates gene expression. A lot of these disorders are due to losing expression of epilepsy genes.”

 

DNA methylation fingerprint offers solution

 

Mefford is exploring epigenetics, the changes in gene expression that may or may not involve DNA alterations, as a potential solution. One such epigenetic change involves a process vital to gene expression called DNA methylation. This process is akin to a chef leaving notes beside a recipe instructing the reader to skip or repeat a step. 

 

“For some genetic disorders, everyone with a mutation in the same gene has a methylation profile across their genome that puts them in a category with all the others with the same genetic disorder,” said Mefford. This methylation landscape is called an “episignature” and is akin to a DEE fingerprint. 

 

While episignatures allowed the researchers to broadly identify DEE-causing variants, taking a closer look at the individual methylation instances, referred to as rare methylation analysis, presented another opportunity. “The underlying cause of the disease ends up manifesting into an episignature that can serve as a marker for that gene,” explained LaFlamme. “With rare methylation events, their analysis can point directly to the cause of the disease.”

 

New technologies aid in rare methylation detection

 

Exploring these rare methylation events across the genome using long-read DNA sequencing pointed the researchers toward DNA regions that are not commonly assessed, offering an answer to the cause of these cases.

 

This one-two punch allowed the researchers to identify the causative and candidate etiologies of DEEs in 2% of previously unidentified cases. This represents another significant step in identifying rare instances of DEEs and another tool to aid in diagnosing children with DEE. 

 

Mefford is determined to continue chipping away in earnest. Her placement within the St. Jude Pediatric Translational Neuroscience Initiative means the so-called “N of few,” the rarer occurrences of neurological disorders like DEE, can continue to be tackled.

 

“We are still dedicated to trying to solve the remaining cases. We’ve always leveraged new technologies, such as next-generation sequencing 10 years ago and now methylation analysis and long-read sequencing,” said Mefford. “We’re always looking for technologies that will give us new information to try and solve those cases.”

 

Authors and funding

The study’s other first author is Cassandra Rastin of Western University. The study’s other co-corresponding author is Bekim Sadikovic of Western University. Other authors include Soham Sengupta, Emily Bonkowski, Edith Almanza Fuerte, Emily Walker, Daniel Darnell, Scott Olsen, Pandurang Kolekar, Nahdir Djekidel, Wojciech Rosikiewicz, Geoffrey Neale, and Zhaoming Wang of St. Jude; Helen Pennington of St. Jude and Rhodes College; Sophie Russ-Hall, Amy Schneider, Talia Allan, Samuel Berkovic and Ingrid Scheffer of the University of Melbourne; Miranda Galey, Joy Goffena, Sophia Gibson, Malavika Hebbar, and Danny Miller of the University of Washington and Seattle Children’s Hospital; Denis Nyaga, Nico Lieffering, and Lynette Sadleir of the University of Otago; Haley McConkey, Jennifer Kerkhof, Michael A. Levy, and Raissa Relator, of the London Health Science Centre; Dorit Lev and Tally Lerman-Sagie of the Wolfson Medical Center; Kristen Park of the University of Colorado School of Medicine; Marielle Alders of the University of Amsterdam; Gerarda Cappuccio of the Telethon Institute of Genetics and Medicine and Federico II University of Naples; Nicolas Chatron, Gaetan Lesca, and Damien Sanlaville of the University Hospital of Lyon and Claude Bernard Lyon I University; Leigh Demain of the Manchester Centre for Genomic Medicine; David Genevieve of Montpellier University; Tony Roscioli of Neuroscience Research Australia, University of New South Wales, Prince of Wales Hospital, and Sydney Children’s Hospital; Matthew Tedder of Greenwood Genetic Center; Sachin Gupta of The Children’s Hospital at Westmead; Monika Weisz Hubshman, Shamika Ketkar, Hongzheng Dai, Kim Carlyle Worley, and Jill Rosenfeld, of Baylor College of Medicine; Hsiao-Tuan Chao of Baylor College of Medicine, Texas Children’s Hospital, and the McNair Medical Institute; and Gemma Carvill of Northwestern University Feinberg School of Medicine.

 

The study was supported by grants from Citizens United for Research in Epilepsy (CURE) (#631106), the National Institutes of Health (DP5OD033357, U01HG007709, and U01HG007942), the National Human Genome Research Institute (U01 HG011744, UM1 HG006493 and U24 HG011746), the Australian National Health and Medical Research Council (GNT2006841, GNT2010562 and GNT1172897), the American FTrnspilepsy Society, the Health Research Council of New Zealand, Cure Kids New Zealand, the Estate of Ernest Hyam Davis, the Tedd and Mollie Carr Endowment Trust, and the GRIN2B foundation.

 

St. Jude Media Relations Contacts

Chelsea Bryant 
Desk: (901) 595-0564
Cell: (256) 244-2048
chelsea.bryant@stjude.org
media@stjude.org

 

Rae Lyn Hartley
Desk: (901) 595-4419
Cell: (901) 686-2597

raelyn.hartley@stjude.org

media@stjude.org

 

St. Jude Children’s Research Hospital 

St. Jude Children’s Research Hospital is leading the way the world understands, treats and cures childhood cancer, sickle cell disease and other life-threatening disorders. It is the only National Cancer Institute–designated Comprehensive Cancer Center devoted solely to children. Treatments developed at St. Jude have helped push the overall childhood cancer survival rate from 20% to 80% since the hospital opened more than 60 years ago. St. Jude shares the breakthroughs it makes to help doctors and researchers at local hospitals and cancer centers around the world improve the quality of treatment and care for even more children. To learn more, visit stjude.org, read Progress: A Digital Magazine and follow St. Jude on social media at @stjuderesearch.  

 

END


[Attachments] See images for this press release:
Genetic ‘episignatures’ guide researchers in identifying causes of unsolved epileptic neurological disorders

ELSE PRESS RELEASES FROM THIS DATE:

Study explores effects of racial discrimination on Black parents and children

Study explores effects of racial discrimination on Black parents and children
2024-08-06
URBANA, Ill. – Black Americans experience racial discrimination on a regular basis, and it is a cause of chronic and pervasive stress. It is known to contribute to elevated risk for poor mental health outcomes, but most research has focused on individuals. A new study from the University of Illinois Urbana-Champaign looks at the interpersonal effects of discrimination on parents and their adolescent children. “A person’s experiences with racial discrimination are not just their own but may spill over into the ...

Wayne State University professor receives career achievement award from the Society for Health Psychology

Wayne State University professor receives career achievement award from the Society for Health Psychology
2024-08-06
DETROIT — Mark Lumley, Ph.D., distinguished professor of psychology in Wayne State University’s College of Liberal Arts and Sciences, was recently awarded the 2024 Nathan W. Perry, Jr. Award for Career Service to Health Psychology from the Society for Health Psychology. The Society for Health Psychology is a national nonprofit that seeks to improve the lives of individuals and society by promoting health, preventing illness and improving health care through research, practice, education, training and advocacy. “I’m delighted and greatly honored for this recognition,” ...

Elephants on the move: Mapping connections across African landscapes

Elephants on the move: Mapping connections across African landscapes
2024-08-06
URBANA, Ill. -- Elephant conservation is a major priority in southern Africa, but habitat loss and urbanization mean the far-ranging pachyderms are increasingly restricted to protected areas like game reserves. The risk? Contained populations could become genetically isolated over time, making elephants more vulnerable to disease and environmental change.  A recent study from the University of Illinois Urbana-Champaign and the University of Pretoria in South Africa demonstrates how African conservation managers could create and optimize elephant movement corridors across a seven-country ...

Youth mental health-related emergency room trips declined significantly after Illinois ended COVID-19 lockdown

2024-08-06
Social media’s rise to popularity between 2010 and 2020 has been strongly correlated with the nationwide freefall in youth mental health that characterized the 2010s. Lawmakers have put increasing pressure on the U.S. government to take social media regulation more seriously, with cases about platforms like Facebook, Instagram and X rising to the Supreme Court level. But despite the ubiquity of social media, scientists at Northwestern Medicine and Ann & Robert H. Lurie Children’s Hospital of Chicago found that in Illinois, youth emergency room visits and hospitalizations for depression and anxiety decreased ...

How plants become bushy, or not

How plants become bushy, or not
2024-08-06
or many plants, more branches means more fruit. But what causes a plant to grow branches? New research from the University of California, Davis shows how plants break down the hormone strigolactone, which suppresses branching, to become more “bushy.” Understanding how strigolactone is regulated could have big implications for many crop plants. The study was published August 1 in Nature Communications. “Being able to manipulate strigolactone could also have implications beyond plant architecture, including on a plant’s resilience to drought and pathogens,” said senior author Nitzan Shabek, an associate professor in the UC Davis Department of ...

Research spotlight: Identifying potential new protein targets for melanoma therapeutics

2024-08-06
How would you summarize your study for a lay audience? Some proteins, such as programmed cell death protein 1 (PD1), can stop the immune system from attacking cancer cells and, therefore, support the growth of cancer. Therapies targeting these proteins can be highly effective, but tumors can become resistant. We applied a method to detect proteins on a single–cell level to uncover human carcinoembryonic antigen cell adhesion molecule 1 (CEACAM1) patterns in melanoma. We found that increased ...

Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators

2024-08-06
Damon Runyon Cancer Research Foundation awards $5.2 million to top clinical investigators The Damon Runyon Cancer Research Foundation has named six new Damon Runyon Clinical Investigators. The recipients of this prestigious award are outstanding, early-career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation's leading scientists and clinicians. The Clinical Investigator Award program was designed to increase the number of physicians capable of translating scientific discoveries into new treatments for cancer patients. Each Awardee will receive $600,000 over three years, ...

Good outcomes 10 years after surgery for ectopic bone in thoracic spine

2024-08-06
August 6, 2024 — Thoracic ossification of the posterior longitudinal ligament (TOPLL) is a rare condition associated with ectopic bone formation in the thoracic spine. A long-term follow-up study from Japan shows significant and lasting improvement in outcomes with posterior decompression and fixation surgery for patients with T-OPLL, reports The Journal of Bone & Joint Surgery. The journal is published in the Lippincott portfolio by Wolters Kluwer.  "Surgical treatment of T-OPLL is effective in improving neurological function, quality ...

Dopamine treatment alleviates symptoms in Alzheimer’s disease

Dopamine treatment alleviates symptoms in Alzheimer’s disease
2024-08-06
A new way to combat Alzheimer’s disease has been discovered by Takaomi Saido and his team at the RIKEN Center for Brain Science (CBS) in Japan. Using mice with the disease, the researchers found that treatment with dopamine could alleviate physical symptoms in the brain as well as improve memory. Published in the scientific journal Science Signaling on August 6, the study examines dopamine’s role in promoting the production of neprilysin, an enzyme that can break down the harmful plaques in the brain that are the ...

Do your supplements contain potentially hepatoxic botanicals?

2024-08-06
Millions of Americans consume supplements that contain potentially hepatoxic botanical ingredients, according to a study from University of Michigan researchers. Over a 30-day period, 4.7% of the adults surveyed in the National Health and Nutrition Examination Survey conducted from 2017 to 2020 took herbal and dietary supplements containing at least one of the botanicals of interest: turmeric; green tea; ashwagandha; black cohosh; garcinia cambogia; and red yeast rice containing products. The resulting paper, “Estimated Exposure ...

LAST 30 PRESS RELEASES:

A third of licensed GPs in England not working in NHS general practice

ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle

Engineers uncover why tiny particles form clusters in turbulent air

GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients

Psoriasis linked to increased risk of vision-threatening eye disease, study finds

Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity

Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests

Resistance training may improve nerve health, slow aging process, study shows

Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer

SwRI-built instruments to monitor, provide advanced warning of space weather events

Breakthrough advances sodium-based battery design

New targeted radiation therapy shows near-complete response in rare sarcoma patients

Does physical frailty contribute to dementia?

Soccer headers and brain health: Study finds changes within folds of the brain

Decoding plants’ language of light

UNC Greensboro study finds ticks carrying Lyme disease moving into western NC

New implant restores blood pressure balance after spinal cord injury

New York City's medical specialist advantage may be an illusion, new NYU Tandon research shows

Could a local anesthetic that doesn’t impair motor function be within reach?

1 in 8 Italian cetacean strandings show evidence of fishery interactions, with bottlenose and striped dolphins most commonly affected, according to analysis across four decades of data and more than 5

In the wild, chimpanzees likely ingest the equivalent of several alcoholic drinks every day

Warming of 2°C intensifies Arctic carbon sink but weakens Alpine sink, study finds

Bronze and Iron Age cultures in the Middle East were committed to wine production

Indian adolescents are mostly starting their periods at an earlier age than 25 years ago

Temporary medical centers in Gaza known as "Medical Points" (MPs) treat an average of 117 people daily with only about 7 staff per MP

Rates of alcohol-induced deaths among the general population nearly doubled from 1999 to 2024

PLOS One study: In adolescent lab animals exposed to cocaine, High-Intensity Interval Training boosts aversion to the drug

Scientists identify four ways our bodies respond to COVID-19 vaccines

Stronger together: A new fusion protein boosts cancer immunotherapy

Hidden brain waves as triggers for post-seizure wandering

[Press-News.org] Genetic ‘episignatures’ guide researchers in identifying causes of unsolved epileptic neurological disorders